Report Code: A13361 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Restless legs syndrome refers to the strong urge to move legs. It can also cause unpleasant crawling or peristaltic sensations in the feet, calves, and thighs. The feeling is usually worse at evening or at night times. Restless legs syndrome is also related to involuntary moving of the legs and arms, called periodic limb movement during sleep (PLMS). There is no exact cause of this syndrome but iron deficiency anemia, kidney failure, last three months of pregnant women, and idiopathic can be the cause of this syndrome. Adoption of good sleeping habits, quitting smoking, and regular exercise are recommended with medication.
COVID-19 Impact Analysis            Â
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the global restless legs syndrome market.
Top Impacting Factors
Market Trends
R&D Activities for Launch of Novel Products
In 2021, new observational study by the non-profit research institute RTI International found that individuals have a significantly higher likelihood of developing restless legs syndrome (RLS) when consuming medications commonly used to reduce acid reflux
In 2019, Serina Therapeutics developed rotigotine, officially known as SER-214, a dopamine agonist for the treatment of restless legs syndrome (RLS). If the trial is successful, it will significantly change the treatment pattern of patients and doctors around the world.
Key Benefits of the Report
Questions Answered in the Global Restless Legs Syndrome Market Report      Â
Restless Leg Syndrome Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Drugs |
|
By Route of Administration |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Intas Pharmaceuticals Ltd, Endo Pharmaceuticals Inc, Mylan N.V., Macleods Pharmaceuticals Ltd., Serina Therapeutics, Novartis AG, Apotex Inc, Aurobindo Pharma, Alembic Pharmaceuticals Limited, Dr. Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Zydus Cadila, Strides Pharma Science Limited |
Loading Table Of Content...
Start reading.
This Report and over 71,251+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers